Balance Sheet
Cash Flow Statement
Beginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Healthy Extracts (HYEX) Change in Accured Expenses (2016 - 2025)

Healthy Extracts' Change in Accured Expenses history spans 11 years, with the latest figure at $138.0 for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 99.59% year-over-year to $138.0; the TTM value through Dec 2025 reached $7348.0, down 75.86%, while the annual FY2025 figure was $7348.0, 75.86% down from the prior year.
  • Change in Accured Expenses reached $138.0 in Q4 2025 per HYEX's latest filing, down from $31823.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $75661.0 in Q3 2023 to a low of -$51217.0 in Q4 2023.
  • Average Change in Accured Expenses over 5 years is $5136.2, with a median of $4868.5 recorded in 2021.
  • Peak YoY movement for Change in Accured Expenses: tumbled 2773.75% in 2021, then soared 451.95% in 2023.
  • A 5-year view of Change in Accured Expenses shows it stood at -$13850.0 in 2021, then soared by 40.19% to -$8284.0 in 2022, then crashed by 518.26% to -$51217.0 in 2023, then soared by 164.94% to $33261.0 in 2024, then crashed by 99.59% to $138.0 in 2025.
  • Per Business Quant, the three most recent readings for HYEX's Change in Accured Expenses are $138.0 (Q4 2025), $31823.0 (Q3 2025), and -$30950.0 (Q2 2025).